JPH07503135A - Ｈｉｖ‐１の標的核酸配列を増幅及び検出する方法 - Google Patents

Ｈｉｖ‐１の標的核酸配列を増幅及び検出する方法

Info

Publication number: JPH07503135A
Authority: JP; Japan
Prior art keywords: sample; hiv; nucleic acid; accession number; target nucleic
Prior art date: 1992-01-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP5512640A

Other languages

English (en)

Japanese (ja)

Inventor

ヘンラード，デニス・アール

ミムス，ラリー・テイー

ゼルデイス，ジエローム・ビー

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Individual

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-01-13

Filing date

1993-01-13

Publication date

1995-04-06

1993-01-13 Application filed by Individual filed Critical Individual

1995-04-06 Publication of JPH07503135A publication Critical patent/JPH07503135A/ja

Status Pending legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims description 108
150000007523 nucleic acids Chemical group 0.000 title claims description 59
241000713772 Human immunodeficiency virus 1 Species 0.000 title claims description 22
239000000523 sample Substances 0.000 claims description 79
238000003752 polymerase chain reaction Methods 0.000 claims description 40
239000011859 microparticle Substances 0.000 claims description 31
239000012472 biological sample Substances 0.000 claims description 30
108020004707 nucleic acids Proteins 0.000 claims description 28
102000039446 nucleic acids Human genes 0.000 claims description 28
239000007787 solid Substances 0.000 claims description 24
238000001514 detection method Methods 0.000 claims description 23
238000009396 hybridization Methods 0.000 claims description 20
108091028043 Nucleic acid sequence Proteins 0.000 claims description 19
230000003321 amplification Effects 0.000 claims description 16
238000003199 nucleic acid amplification method Methods 0.000 claims description 16
238000004458 analytical method Methods 0.000 claims description 11
239000002245 particle Substances 0.000 claims description 11
239000000463 material Substances 0.000 claims description 9
238000007834 ligase chain reaction Methods 0.000 claims description 8
239000000126 substance Substances 0.000 claims description 8
210000004408 hybridoma Anatomy 0.000 claims description 7
108091005804 Peptidases Proteins 0.000 claims description 5
230000002452 interceptive effect Effects 0.000 claims description 5
108020004414 DNA Proteins 0.000 claims description 4
102000053602 DNA Human genes 0.000 claims description 4
238000004587 chromatography analysis Methods 0.000 claims description 4
238000004925 denaturation Methods 0.000 claims description 4
230000036425 denaturation Effects 0.000 claims description 4
108010067770 Endopeptidase K Proteins 0.000 claims description 3
102000035195 Peptidases Human genes 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 claims description 3
238000011033 desalting Methods 0.000 claims description 3
239000007791 liquid phase Substances 0.000 claims description 3
235000019833 protease Nutrition 0.000 claims description 3
229920002477 rna polymer Polymers 0.000 claims description 2
239000000427 antigen Substances 0.000 description 58
108091007433 antigens Proteins 0.000 description 57
102000036639 antigens Human genes 0.000 description 57
238000003556 assay Methods 0.000 description 57
241000700605 Viruses Species 0.000 description 54
210000002966 serum Anatomy 0.000 description 47
108091032973 (ribonucleotides)n+m Proteins 0.000 description 39
101710205625 Capsid protein p24 Proteins 0.000 description 30
101710177166 Phosphoprotein Proteins 0.000 description 30
101710149279 Small delta antigen Proteins 0.000 description 30
210000002381 plasma Anatomy 0.000 description 29
241000725303 Human immunodeficiency virus Species 0.000 description 27
208000015181 infectious disease Diseases 0.000 description 25
238000012360 testing method Methods 0.000 description 24
230000035945 sensitivity Effects 0.000 description 23
239000000203 mixture Substances 0.000 description 17
239000013615 primer Substances 0.000 description 17
210000004027 cell Anatomy 0.000 description 14
239000012634 fragment Substances 0.000 description 14
102100034343 Integrase Human genes 0.000 description 13
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 13
239000002953 phosphate buffered saline Substances 0.000 description 12
230000003612 virological effect Effects 0.000 description 12
210000004369 blood Anatomy 0.000 description 11
239000008280 blood Substances 0.000 description 11
239000000243 solution Substances 0.000 description 11
230000002458 infectious effect Effects 0.000 description 10
239000007788 liquid Substances 0.000 description 10
206010058874 Viraemia Diseases 0.000 description 8
239000000872 buffer Substances 0.000 description 8
239000010419 fine particle Substances 0.000 description 8
208000006454 hepatitis Diseases 0.000 description 8
208000002672 hepatitis B Diseases 0.000 description 8
210000001519 tissue Anatomy 0.000 description 8
239000007983 Tris buffer Substances 0.000 description 7
231100000283 hepatitis Toxicity 0.000 description 7
239000013642 negative control Substances 0.000 description 7
239000002773 nucleotide Substances 0.000 description 7
125000003729 nucleotide group Chemical group 0.000 description 7
239000000047 product Substances 0.000 description 7
239000011541 reaction mixture Substances 0.000 description 7
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 7
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 6
208000030507 AIDS Diseases 0.000 description 6
239000008188 pellet Substances 0.000 description 6
230000001566 pro-viral effect Effects 0.000 description 6
230000000405 serological effect Effects 0.000 description 6
239000007790 solid phase Substances 0.000 description 6
239000006228 supernatant Substances 0.000 description 6
238000002965 ELISA Methods 0.000 description 5
241000711549 Hepacivirus C Species 0.000 description 5
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
230000001154 acute effect Effects 0.000 description 5
230000001745 anti-biotin effect Effects 0.000 description 5
230000036436 anti-hiv Effects 0.000 description 5
238000006243 chemical reaction Methods 0.000 description 5
239000012228 culture supernatant Substances 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
108090000623 proteins and genes Proteins 0.000 description 5
238000001179 sorption measurement Methods 0.000 description 5
238000005406 washing Methods 0.000 description 5
101710132601 Capsid protein Proteins 0.000 description 4
108010010803 Gelatin Proteins 0.000 description 4
241000700721 Hepatitis B virus Species 0.000 description 4
239000002585 base Substances 0.000 description 4
238000005119 centrifugation Methods 0.000 description 4
239000002299 complementary DNA Substances 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000001962 electrophoresis Methods 0.000 description 4
239000008273 gelatin Substances 0.000 description 4
229920000159 gelatin Polymers 0.000 description 4
235000019322 gelatine Nutrition 0.000 description 4
235000011852 gelatine desserts Nutrition 0.000 description 4
230000008569 process Effects 0.000 description 4
238000004393 prognosis Methods 0.000 description 4
230000009870 specific binding Effects 0.000 description 4
-1 tissue culture cells Substances 0.000 description 4
230000029812 viral genome replication Effects 0.000 description 4
241000894006 Bacteria Species 0.000 description 3
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
108010027044 HIV Core Protein p24 Proteins 0.000 description 3
241000709721 Hepatovirus A Species 0.000 description 3
238000002944 PCR assay Methods 0.000 description 3
229920001213 Polysorbate 20 Polymers 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
208000036142 Viral infection Diseases 0.000 description 3
230000002159 abnormal effect Effects 0.000 description 3
238000000137 annealing Methods 0.000 description 3
239000011324 bead Substances 0.000 description 3
230000027455 binding Effects 0.000 description 3
230000001684 chronic effect Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
238000003745 diagnosis Methods 0.000 description 3
238000007865 diluting Methods 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
238000002955 isolation Methods 0.000 description 3
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
102000004169 proteins and genes Human genes 0.000 description 3
238000000746 purification Methods 0.000 description 3
230000010076 replication Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
239000000725 suspension Substances 0.000 description 3
208000024891 symptom Diseases 0.000 description 3
230000009385 viral infection Effects 0.000 description 3
210000000605 viral structure Anatomy 0.000 description 3
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
208000031886 HIV Infections Diseases 0.000 description 2
208000037262 Hepatitis delta Diseases 0.000 description 2
241000724709 Hepatitis delta virus Species 0.000 description 2
241000282414 Homo sapiens Species 0.000 description 2
108091034117 Oligonucleotide Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
101150010882 S gene Proteins 0.000 description 2
240000004808 Saccharomyces cerevisiae Species 0.000 description 2
239000012506 Sephacryl® Substances 0.000 description 2
108020004682 Single-Stranded DNA Proteins 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
101000874347 Streptococcus agalactiae IgA FC receptor Proteins 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
108020005202 Viral DNA Proteins 0.000 description 2
108020000999 Viral RNA Proteins 0.000 description 2
239000002253 acid Substances 0.000 description 2
239000012491 analyte Substances 0.000 description 2
238000000211 autoradiogram Methods 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
230000000295 complement effect Effects 0.000 description 2
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
238000000326 densiometry Methods 0.000 description 2
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 2
229960005542 ethidium bromide Drugs 0.000 description 2
230000009395 genetic defect Effects 0.000 description 2
239000004816 latex Substances 0.000 description 2
229920000126 latex Polymers 0.000 description 2
239000003446 ligand Substances 0.000 description 2
239000006166 lysate Substances 0.000 description 2
239000003550 marker Substances 0.000 description 2
239000012528 membrane Substances 0.000 description 2
244000005700 microbiome Species 0.000 description 2
239000003607 modifier Substances 0.000 description 2
230000004962 physiological condition Effects 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
235000019419 proteases Nutrition 0.000 description 2
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
230000008685 targeting Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
VQDXQECDZXHUQT-UHFFFAOYSA-N 3-(iminomethylideneamino)propan-1-amine Chemical compound NCCCN=C=N VQDXQECDZXHUQT-UHFFFAOYSA-N 0.000 description 1
206010059193 Acute hepatitis B Diseases 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
241000972773 Aulopiformes Species 0.000 description 1
108091005658 Basic proteases Proteins 0.000 description 1
241000167854 Bourreria succulenta Species 0.000 description 1
108090000317 Chymotrypsin Proteins 0.000 description 1
241000701022 Cytomegalovirus Species 0.000 description 1
108020003215 DNA Probes Proteins 0.000 description 1
229940123014 DNA polymerase inhibitor Drugs 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010059378 Endopeptidases Proteins 0.000 description 1
102000005593 Endopeptidases Human genes 0.000 description 1
QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
101150087426 Gnal gene Proteins 0.000 description 1
208000037357 HIV infectious disease Diseases 0.000 description 1
206010019799 Hepatitis viral Diseases 0.000 description 1
241000238631 Hexapoda Species 0.000 description 1
241000282412 Homo Species 0.000 description 1
241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
241000701806 Human papillomavirus Species 0.000 description 1
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
102000043276 Oncogene Human genes 0.000 description 1
108700020796 Oncogene Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
241000282577 Pan troglodytes Species 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
108010059712 Pronase Proteins 0.000 description 1
101150023114 RNA1 gene Proteins 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
108090000787 Subtilisin Proteins 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
241000384512 Trachichthyidae Species 0.000 description 1
101800001690 Transmembrane protein gp41 Proteins 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
108010067390 Viral Proteins Proteins 0.000 description 1
QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
239000008186 active pharmaceutical agent Substances 0.000 description 1
208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
239000003513 alkali Substances 0.000 description 1
238000005275 alloying Methods 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
230000002155 anti-virotic effect Effects 0.000 description 1
230000005875 antibody response Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
238000013459 approach Methods 0.000 description 1
238000000376 autoradiography Methods 0.000 description 1
239000011230 binding agent Substances 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
229960002685 biotin Drugs 0.000 description 1
235000020958 biotin Nutrition 0.000 description 1
239000011616 biotin Substances 0.000 description 1
210000001124 body fluid Anatomy 0.000 description 1
239000010839 body fluid Substances 0.000 description 1
210000000481 breast Anatomy 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
239000013626 chemical specie Substances 0.000 description 1
235000019693 cherries Nutrition 0.000 description 1
208000016350 chronic hepatitis B virus infection Diseases 0.000 description 1
229960002376 chymotrypsin Drugs 0.000 description 1
208000019425 cirrhosis of liver Diseases 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000008878 coupling Effects 0.000 description 1
238000010168 coupling process Methods 0.000 description 1
238000005859 coupling reaction Methods 0.000 description 1
238000012258 culturing Methods 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
WRTKMPONLHLBBL-KVQBGUIXSA-N dXTP Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(NC(=O)NC2=O)=C2N=C1 WRTKMPONLHLBBL-KVQBGUIXSA-N 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000010612 desalination reaction Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
230000010339 dilation Effects 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
231100000676 disease causative agent Toxicity 0.000 description 1
239000006185 dispersion Substances 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
239000003814 drug Substances 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000001493 electron microscopy Methods 0.000 description 1
229910001651 emery Inorganic materials 0.000 description 1
229940066758 endopeptidases Drugs 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000000284 extract Substances 0.000 description 1
238000000605 extraction Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
230000004927 fusion Effects 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
230000002068 genetic effect Effects 0.000 description 1
239000011491 glass wool Substances 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
108091008039 hormone receptors Proteins 0.000 description 1
208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
150000003949 imides Chemical class 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000009169 immunotherapy Methods 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
239000000543 intermediate Substances 0.000 description 1
238000011835 investigation Methods 0.000 description 1
238000005342 ion exchange Methods 0.000 description 1
208000019423 liver disease Diseases 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
239000002609 medium Substances 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
244000052769 pathogen Species 0.000 description 1
230000008506 pathogenesis Effects 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
150000008300 phosphoramidites Chemical group 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
235000015277 pork Nutrition 0.000 description 1
239000013641 positive control Substances 0.000 description 1
238000012545 processing Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000011158 quantitative evaluation Methods 0.000 description 1
238000002601 radiography Methods 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
239000000376 reactant Substances 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000002976 reverse transcriptase assay Methods 0.000 description 1
238000010839 reverse transcription Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
235000019515 salmon Nutrition 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000009738 saturating Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000013207 serial dilution Methods 0.000 description 1
238000011895 specific detection Methods 0.000 description 1
229940063673 spermidine Drugs 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
239000000758 substrate Substances 0.000 description 1
208000010648 susceptibility to HIV infection Diseases 0.000 description 1
210000001179 synovial fluid Anatomy 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
238000002560 therapeutic procedure Methods 0.000 description 1
238000004448 titration Methods 0.000 description 1
238000013518 transcription Methods 0.000 description 1
230000035897 transcription Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
241001529453 unidentified herpesvirus Species 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
230000005570 vertical transmission Effects 0.000 description 1
239000000052 vinegar Substances 0.000 description 1
235000021419 vinegar Nutrition 0.000 description 1
201000001862 viral hepatitis Diseases 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- G01N33/56988—HIV or HTLV

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Molecular Biology (AREA)
Analytical Chemistry (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Hematology (AREA)
Genetics & Genomics (AREA)
AIDS & HIV (AREA)
Pathology (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
Cell Biology (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
General Physics & Mathematics (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Saccharide Compounds (AREA)

JP5512640A 1992-01-13 1993-01-13 Ｈｉｖ‐１の標的核酸配列を増幅及び検出する方法 Pending JPH07503135A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US81955592A	1992-01-13	1992-01-13
US819,555		1992-01-13
PCT/US1993/000295 WO1993014225A1 (fr)	1992-01-13	1993-01-13	Procede d'amplification et de detection d'une sequence d'acides nucleiques cible de hiv-1

Publications (1)

Publication Number	Publication Date
JPH07503135A true JPH07503135A (ja)	1995-04-06

Family

ID=25228464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP5512640A Pending JPH07503135A (ja)	1992-01-13	1993-01-13	Ｈｉｖ‐１の標的核酸配列を増幅及び検出する方法

Country Status (5)

Country	Link
EP (1)	EP0672176A4 (fr)
JP (1)	JPH07503135A (fr)
AU (1)	AU3471593A (fr)
CA (1)	CA2127883A1 (fr)
WO (1)	WO1993014225A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008531039A (ja)	2005-02-28	2008-08-14	バイオクエストインク	核酸分子が含まれる直接酵素反応方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4483920A (en) *	1982-05-17	1984-11-20	Hahnemann University	Immobilization of message RNA directly from cells onto filter material
GB8331071D0 (en) *	1983-11-22	1983-12-29	Karayiannis P	Assay for dna/rna
US4683195A (en) *	1986-01-30	1987-07-28	Cetus Corporation	Process for amplifying, detecting, and/or-cloning nucleic acid sequences
CA1317535C (fr) *	1987-06-30	1993-05-11	Nanibhushan Dattagupta	Essai de sequences a l'aide de genes amplifies
AU622426B2 (en) *	1987-12-11	1992-04-09	Abbott Laboratories	Assay using template-dependent nucleic acid probe reorganization
US5104791A (en) *	1988-02-09	1992-04-14	E. I. Du Pont De Nemours And Company	Particle counting nucleic acid hybridization assays
US4988617A (en) *	1988-03-25	1991-01-29	California Institute Of Technology	Method of detecting a nucleotide change in nucleic acids
US5077192A (en) *	1988-10-25	1991-12-31	The General Hospital Corporation	Method of detecting antigenic, nucleic acid-containing macromolecular entities
IE64040B1 (en) *	1989-06-15	1995-06-28	Akzo Nv	Method for determining nucleic acid

1993
- 1993-01-13 EP EP93903459A patent/EP0672176A4/fr not_active Withdrawn
- 1993-01-13 CA CA 2127883 patent/CA2127883A1/fr not_active Abandoned
- 1993-01-13 WO PCT/US1993/000295 patent/WO1993014225A1/fr not_active Ceased
- 1993-01-13 JP JP5512640A patent/JPH07503135A/ja active Pending
- 1993-01-13 AU AU34715/93A patent/AU3471593A/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0672176A4 (fr)	1997-04-09
AU3471593A (en)	1993-08-03
WO1993014225A1 (fr)	1993-07-22
EP0672176A1 (fr)	1995-09-20
CA2127883A1 (fr)	1993-07-22

Publication	Publication Date	Title
JP3490724B2 (ja)	2004-01-26	核酸の定量化
US5534406A (en)	1996-07-09	Method of detecting antigenic nucleic acid-containing macromolecular entities
JP3091492B2 (ja)	2000-09-25	非放射性ハイブリダイゼーションアッセイおよびキット
FI115843B (fi)	2005-07-29	Menetelmiä nukleiinihappojen sitomiseksi ja vapauttamiseksi selektiivisesti heikosti emäksistä polymeeriä käyttäen, sekä näiden monistamiseksi
EP0439222B1 (fr)	1995-10-25	Réactif insoluble, sonde d'acide nucléique, kit de test et procédés de diagnostic et purification
US5403707A (en)	1995-04-04	Diagnostic compositions, elements, methods and test kits for amplification and detection of retroviral DNA using primers having matched melting temperatures
JPH08511954A (ja)	1996-12-17	Ｈｔｌｖ−▲ｉｉ▼▲下ｎｒａ▼構成物およびｈｔｌｖ感染検出用アッセイ
JP2009291200A (ja)	2009-12-17	Ａ型肝炎ウイルス核酸の捕捉、検出および定量のためのオリゴヌクレオチドの同定
JP2010518046A (ja)	2010-05-27	病原体の結合
Zeldis et al.	1989	Direct method for detecting small quantities of hepatitis B virus DNA in serum and plasma using the polymerase chain reaction.
Pao et al.	1991	Serum hepatitis B virus DNA in hepatitis B virus seropositive and seronegative patients with normal liver function
JPH0333656A (ja)	1991-02-13	核酸測定法
US20030143527A1 (en)	2003-07-31	Identification of oligonucleotides for the capture, detection and quantitation of hepatitis B viral DNA
Arkhis et al.	2010	Capture of enveloped viruses using polymer tentacles containing magnetic latex particles
US20130337434A1 (en)	2013-12-19	Method of Preparing Magnetic Bead Type Nasopharyngeal Enzyme Immunoassay Reagents by Polymerase Chain Reaction
JPS63500401A (ja)	1988-02-12	抗体の検出のための競合的エリザ
JPH11510705A (ja)	1999-09-21	肝炎ｇｂウイルスの核酸検出
KR101857417B1 (ko)	2018-05-15	효소면역기법을 이용한 일본뇌염바이러스에 대한 항체 검출 방법
US20070264646A1 (en)	2007-11-15	Hbv Particles Containing Hbv-Rna
AU3471593A (en)	1993-08-03	A method for amplifying and detecting a target nucleic acid sequence of HIV-1
JP2004286749A (ja)	2004-10-14	アッセイサンプルを調製するための方法
JP2957195B2 (ja)	1999-10-04	Ｂ型肝炎ウイルス抗体検出システム
CN117343912A (zh)	2024-01-05	一种兼有呼吸道病毒核酸检测与抗原检测功能的磁珠及其制备方法、应用和试剂盒
JPH04267899A (ja)	1992-09-24	ヒト　ｃ　型肝炎ウイルスゲノムの簡便な検出法
TW201348705A (zh)	2013-12-01	應用聚合酶連鎖反應製備磁珠式鼻咽癌酵素免疫檢驗試劑之方法